{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:12:29Z","timestamp":1791616349057,"version":"4.3.4"},"reference-count":285,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP14096"],"award-info":[{"award-number":["GGP14096"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["19027"],"award-info":[{"award-number":["19027"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2009-1580433"],"award-info":[{"award-number":["GR-2009-1580433"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00121","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T06:00:12Z","timestamp":1462860012000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":150,"title":["Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery"],"prefix":"10.3389","volume":"7","author":[{"given":"Paola","family":"Imbrici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia M.","family":"Camerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"De Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Camerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangela","family":"Giustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabata","family":"Pierno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tricarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Desaphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1523\/JNEUROSCI.6341-09.2010","article-title":"KCa channels as therapeutic targets in episodic ataxia type-2.","volume":"30","author":"Alvina","year":"2010a","journal-title":"J. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1523\/JNEUROSCI.3582-09.2010","article-title":"The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.","volume":"30","author":"Alvina","year":"2010b","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"F1324","DOI":"10.1152\/ajprenal.00004.2015","article-title":"ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3.","volume":"308","author":"Andrini","year":"2015","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"63","key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-63","article-title":"Congenital hyperinsulinism: current trends in diagnosis and therapy.","volume":"6","author":"Arnoux","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1074\/jbc.275.2.717","article-title":"Pharmaco-topology of sulfonylurea receptors. Separate domains of the regulatory subunits of K(ATP) channel isoforms are required for selective interaction with K(+) channel openers.","volume":"275","author":"Babenko","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15432","DOI":"10.1073\/pnas.1112667108","article-title":"Mouse model of Timothy syndrome recapitulates triad of autistic traits.","volume":"108","author":"Bader","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.bmcl.2014.06.038","article-title":"Recent progress in sodium channel modulators for pain.","volume":"24","author":"Bagal","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/hmg\/ddm112","article-title":"Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.","volume":"16","author":"Barlassina","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuropharm.2015.01.005","article-title":"Pharmacology of acid-sensing ion channels - Physiological and therapeutical perspectives.","volume":"94","author":"Baron","year":"2015","journal-title":"Neuropharmacology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv582","article-title":"A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia.","author":"Baruscotti","year":"2015","journal-title":"Eur. Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/1817-1745.84416","article-title":"Megalencephalic leukoencephalopathy with subcortical cysts: a report of four cases.","volume":"6","author":"Batla","year":"2011","journal-title":"J. Pediatr. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.nbd.2014.12.028","article-title":"Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum.","volume":"75","author":"Bechi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/ana.1144","article-title":"Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis.","volume":"50","author":"Bendahhou","year":"2001","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yebeh.2011.11.022","article-title":"SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.","volume":"23","author":"Bender","year":"2012","journal-title":"Epilepsy Behav."},{"key":"B15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S1474-4422(14)70024-9","article-title":"Painful and painless channelopathies.","volume":"13","author":"Bennett","year":"2014","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S0317167100026305","article-title":"Treatment of paramyotonia congenita with acetazolamide.","volume":"14","author":"Benstead","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20029","article-title":"Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy.","volume":"55","author":"Berkovic","year":"2004","journal-title":"Ann. Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/1874467208666150518114857","article-title":"Calcium channel mutations in cardiac arrhythmia syndromes.","volume":"8","author":"Betzenhauser","year":"2015","journal-title":"Curr. Mol. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1523\/JNEUROSCI.0338-07.2007","article-title":"Leukoencephalopathy upon disruption of the chloride channel ClC-2.","volume":"27","author":"Blanz","year":"2007","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa0810276","article-title":"Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations.","volume":"360","author":"Bockenhauer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B21","first-page":"F1132","article-title":"ROMK inwardly rectifying ATP-sensitive K+ channel. II. Cloning and distribution of alternative forms.","volume":"268","author":"Boim","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"66","key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00106","article-title":"MLC1 protein: a likely link between leukodystrophies and brain channelopathies.","volume":"9","author":"Brignone","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","article-title":"Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.","volume":"24","author":"Brochard","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jns5.12071","article-title":"Painful neuropathies: the emerging role of sodium channelopathies.","volume":"19","author":"Brouwer","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"B25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG.","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"issue":"39","key":"B26","doi-asserted-by":"publisher","DOI":"10.5339\/gcsp.2015.39","article-title":"Genetics of channelopathies associated with sudden cardiac death.","volume":"2015","author":"Campuzano","year":"2015","journal-title":"Global Cardiol. Sci. Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/cphy.c140062","article-title":"Channelopathies of skeletal muscle excitability.","volume":"5","author":"Cannon","year":"2015","journal-title":"Compr. Physiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2174\/1568026616666151215104058","article-title":"HCN channels as therapeutic targets for heart failure and pain.","author":"Cao","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"issue":"e248","key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.21","article-title":"Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.","volume":"4","author":"Capulli","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"155","key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00155","article-title":"Inhibition of voltage-gated sodium channels by sumatriptan bioisosteres.","volume":"6","author":"Carbonara","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00415-012-6462-1","article-title":"Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.","volume":"259","author":"Cardani","year":"2012","journal-title":"J. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/chir.20741","article-title":"Synthesis, and in vitro sodium channel blocking activity evaluation of novel homochiral mexiletine analogue.","volume":"22","author":"Carocci","year":"2010","journal-title":"Chirality"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1113\/jphysiol.2011.224204","article-title":"Voltage-gated sodium channels at 60: structure, function and pathophysiology.","volume":"590","author":"Catterall","year":"2012","journal-title":"J. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-pharmtox-011112-140232","article-title":"Sodium channels, inherited epilepsy, and antiepileptic drugs.","volume":"54","author":"Catterall","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1124\/mol.114.097659","article-title":"Structural basis for pharmacology of voltage-gated sodium and calcium channels.","volume":"88","author":"Catterall","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1523-1755.2005.00442.x","article-title":"High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent\u2019s disease.","volume":"68","author":"Cebotaru","year":"2005","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"17546","DOI":"10.1073\/pnas.1309827110","article-title":"Nonfunctional Nav1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects.","volume":"110","author":"Cest\u00e8le","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/33305","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1212\/WNL.0b013e31828868e7","article-title":"Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy.","volume":"80","author":"Chen","year":"2013","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.10607","article-title":"Association between genetic variation of CACNA1H and childhood absence epilepsy.","volume":"54","author":"Chen","year":"2003","journal-title":"Ann. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.mcn.2008.05.009","article-title":"Functional properties and differential neuromodulation of Na(v)1.6 channels.","volume":"38","author":"Chen","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"27425","DOI":"10.1074\/jbc.M111.249656","article-title":"Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemicperiodic paralysis.","volume":"286","author":"Cheng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.expneurol.2008.12.012","article-title":"Mexiletine-responsive erythromelalgia due to a new Nav1.7 mutation showing use-dependent current fall-off.","volume":"216","author":"Choi","year":"2009","journal-title":"Exp. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain.","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/dmcn.12171","article-title":"Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome.","volume":"55","author":"Cross","year":"2013","journal-title":"Dev. Med. Child. Neurol."},{"issue":"525","key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00525","article-title":"Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.","volume":"5","author":"D\u2019Adamo","year":"2015a","journal-title":"Front. Physiol."},{"issue":"317","key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00317","article-title":"New insights into the pathogenesis and therapeutics of episodic ataxia type 1.","volume":"9","author":"D\u2019Adamo","year":"2015b","journal-title":"Front. Cell. Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1212\/01.wnl.0000178888.03767.74","article-title":"Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation.","volume":"65","author":"Davies","year":"2005","journal-title":"Neurology"},{"key":"B49","first-page":"1320","article-title":"Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients.","volume":"141","author":"Davis","year":"2005","journal-title":"Arch. Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bpj.2012.11.3830","article-title":"Combined modifications of mexiletine pharmacophores for new lead blockers of Nav1.4 channels.","volume":"104","author":"De Bellis","year":"2013","journal-title":"Biophys. J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)60098-8","article-title":"The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.","volume":"386","author":"De Franco","year":"2015","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications.","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J. Med. Chem."},{"key":"B53","first-page":"40","article-title":"Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview.","volume":"31","author":"De Luca","year":"2012","journal-title":"Acta Myol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bjp.0702107","article-title":"Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels.","volume":"125","author":"De Luca","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.","volume":"304","author":"De Luca","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.nmd.2004.04.006","article-title":"New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on myotonic ADR mouse.","volume":"14","author":"De Luca","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"B57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)11241-X","article-title":"Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.","volume":"260","author":"De Luca","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5414\/CN107687","article-title":"Severe manifestation of Bartter syndrome Type IV caused by a novel insertion mutation in the BSND gene.","volume":"81","author":"de Pablos","year":"2014","journal-title":"Clin. Nephrol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1474-4422(13)70053-X","article-title":"Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational and alytical study.","volume":"12","author":"Depienne","year":"2013","journal-title":"Lancet Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.expneurol.2014.02.023","article-title":"Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses new promising antimyotonic drugs.","volume":"255","author":"Desaphy","year":"2014","journal-title":"Exp. Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1124\/mol.112.080804","article-title":"Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.","volume":"83","author":"Desaphy","year":"2013a","journal-title":"Mol. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1113\/jphysiol.2003.046995","article-title":"Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.","volume":"554","author":"Desaphy","year":"2004","journal-title":"J. Physiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1212\/WNL.57.10.1849","article-title":"Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative.","volume":"57","author":"Desaphy","year":"2001","journal-title":"Neurology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.expneurol.2013.07.018","article-title":"Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes.","volume":"248","author":"Desaphy","year":"2013b","journal-title":"Exp. Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00228-012-1414-3","article-title":"Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy.","volume":"69","author":"Desaphy","year":"2013c","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0140-6736(05)66786-4","article-title":"Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.","volume":"366","author":"Dichgans","year":"2005","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7861\/clinmedicine.15-4-344","article-title":"Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options.","volume":"15","author":"Diener","year":"2015","journal-title":"Clin. Med. (Lond)."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1002\/ajmg.a.37258","article-title":"Long QT syndrome with craniofacial, digital, and neurologic features: is it useful to distinguish between timothy syndrome types 1 and 2?","volume":"167A","author":"Diep","year":"2015","journal-title":"Am. J. Med. Genet. A."},{"issue":"e40235","key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040235","article-title":"Splicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscle.","volume":"7","author":"Dinardo","year":"2012","journal-title":"PLoS ONE"},{"key":"B70","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/ana.23700","article-title":"Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.","volume":"72","author":"Duarri","year":"2012","journal-title":"Ann. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1113\/jphysiol.2013.264176","article-title":"Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.","volume":"592","author":"Eckle","year":"2014","journal-title":"J. Physiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/mus.20585","article-title":"Acetazolamide acts directly on the human skeletal muscle chloride channel.","volume":"34","author":"Eguchi","year":"2006","journal-title":"Muscle Nerve"},{"key":"B73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2015.09.002","article-title":"Role of pharmacotherapy in cardiac ion channelopathies.","volume":"155","author":"El-Sherif","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1152\/jn.00195.2015","article-title":"Ca2+ toxicity due to reverse Na+\/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation.","volume":"114","author":"Estacion","year":"2015","journal-title":"J. Neurophysiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/35107099","article-title":"Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.","volume":"414","author":"Est\u00e9vez","year":"2001","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ana.22485","article-title":"Gain of function Na(V) 1.7 mutations in idiopathic small fiber neuropathy.","volume":"71","author":"Faber","year":"2012a","journal-title":"Ann. Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function Nav1.8 mutations in painful neuropathy.","volume":"109","author":"Faber","year":"2012b","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B78","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1126\/science.1195230","article-title":"Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle.","volume":"330","author":"Feng","year":"2010","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron"},{"key":"B80","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000268065.16865.5f","article-title":"Paroxysmal extreme pain disorder (previously familial rectal pain syndrome).","volume":"69","author":"Fertleman","year":"2007","journal-title":"Neurology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ana.21678","article-title":"A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.","volume":"65","author":"Fischer","year":"2009","journal-title":"Ann. Neurol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1474-4422(14)70239-X","article-title":"Neuromuscular diseases: progress in gene discovery drives diagnostics and therapeutics.","volume":"14","author":"Fratta","year":"2015","journal-title":"Lancet Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.nmd.2014.06.439","article-title":"Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.","volume":"24","author":"Furby","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"B85","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment.","volume":"43","author":"Gaita","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2013.11.005","article-title":"Targeting the inward-rectifier potassium channel ROMK in cardiovascular disease.","volume":"15","author":"Garcia","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1124\/jpet.113.208603","article-title":"Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.","volume":"348","author":"Garcia","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.neuroscience.2010.05.019","article-title":"Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.","volume":"169","author":"Ghelardini","year":"2010","journal-title":"Neuroscience"},{"key":"B89","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cpcardiol.2013.08.001","article-title":"Genotype- and phenotype-guided management of congenital long QT syndrome.","volume":"38","author":"Giudicessi","year":"2013","journal-title":"Curr. Probl. Cardiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbd.2008.06.002","article-title":"Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2.","volume":"32","author":"Graves","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2014.01.017","article-title":"Kv7 channels as targets for anti-epileptic and psychiatric drug-development.","volume":"726","author":"Grunnet","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"34","key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00034","article-title":"Update on the implication of potassium channels in autism: K+ channelautism spectrum disorder.","volume":"9","author":"Guglielmi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1212\/WNL.0000000000002264","article-title":"A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis.","volume":"86","author":"Habbout","year":"2016","journal-title":"Neurology"},{"key":"B95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-662-46450-2_3","article-title":"Sodium Channels and Pain.","volume":"227","author":"Habib","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jnnp-2013-306095","article-title":"The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.","volume":"85","author":"Han","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jacc.2015.10.020","article-title":"A Tale of 2 Diseases: the history of long-QT syndrome and brugada syndrome.","volume":"67","author":"Havakuk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nn1025","article-title":"A mouse model of episodic ataxia type-1.","volume":"6","author":"Herson","year":"2003","journal-title":"Nat. Neurosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pneurobio.2015.09.002","article-title":"Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders.","volume":"134","author":"Heyes","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00021.2009","article-title":"Inwardly rectifying potassium channels: their structure, function, and physiological roles.","volume":"90","author":"Hibino","year":"2010","journal-title":"Physiol. Rev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/sj.ki.5002785","article-title":"Dent disease presenting as partial Fanconi syndrome and hypercalciuria.","volume":"73","author":"Hodgin","year":"2008","journal-title":"Kidney Int."},{"issue":"3475","key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4475","article-title":"Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction.","volume":"5","author":"Hoegg-Beiler","year":"2014","journal-title":"Nat. Commun."},{"key":"B103","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/19336950.2015.1089007","article-title":"Role of volume-regulated and calcium-activated anion channels in cell volume homeostasis, cancer and drug resistance.","volume":"9","author":"Hoffmann","year":"2015","journal-title":"Channels (Austin)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/brain\/awu079","article-title":"Gain-of-function sodium channel Nav1.9 mutations in painful neuropathy.","volume":"137","author":"Huang","year":"2014","journal-title":"Brain"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1177\/1087057115601677","article-title":"Neuronal and cardiovascular potassium channels as therapeutic drug targets: promise and pitfalls.","volume":"20","author":"Humphries","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"B106","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.eplepsyres.2012.03.019","article-title":"The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events.","volume":"101","author":"Igelstr\u00f6m","year":"2012","journal-title":"Epilepsy Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12311-013-0531-6","article-title":"Consensus paper: management of degenerative cerebellar disorders.","volume":"13","author":"Ilg","year":"2014","journal-title":"Cerebellum"},{"issue":"156","key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00156","article-title":"ClC-1 chloride channels: state-of-the-art research and future challenges.","volume":"9","author":"Imbrici","year":"2015a","journal-title":"Front. Cell. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"C1314","DOI":"10.1152\/ajpcell.00456.2010","article-title":"Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.","volume":"300","author":"Imbrici","year":"2011","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.bbamem.2014.05.017","article-title":"Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.","volume":"1838","author":"Imbrici","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1113\/JP270358","article-title":"ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation.","volume":"593","author":"Imbrici","year":"2015b","journal-title":"J. Physiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1113\/jphysiol.2011.224212","article-title":"Voltage-gated potassium channels and the diversity of electrical congenita.","volume":"590","author":"Jan","year":"2012","journal-title":"J. Physiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1681\/ASN.2008010102","article-title":"Disease-causing dysfunctions of barttin in Bartter syndrome type IV.","volume":"20","author":"Janssen","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1172\/JCI40801","article-title":"Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents.","volume":"120","author":"Jarecki","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B115","article-title":"Familial Hemiplegic Migraine","author":"Jen","year":"2015","journal-title":"GeneReviews [Internet]"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/brain\/awm126","article-title":"Primary episodic ataxias: diagnosis, pathogenesis and treatment.","volume":"130","author":"Jen","year":"2007","journal-title":"Brain"},{"key":"B117","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1113\/JP270043","article-title":"Discovery of CLC transport proteins: cloning, structure, function and pathophysiology.","volume":"593","author":"Jentsch","year":"2015","journal-title":"J. Physiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/jhg.2012.20","article-title":"A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemicperiodic paralysis.","volume":"57","author":"Jongjaroenprasert","year":"2012","journal-title":"J. Hum. Genet."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1111\/bph.12414","article-title":"Transient receptor potential (TRP) channels: a clinical perspective.","volume":"171","author":"Kaneko","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/sj.emboj.7600576","article-title":"Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.","volume":"24","author":"Kasper","year":"2005","journal-title":"EMBO J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.gde.2010.12.007","article-title":"Genetic modifiers of neurological disease.","volume":"21","author":"Kearney","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","article-title":"Long-term treatment of osteopetrosis with recombinant human interferon gamma.","volume":"332","author":"Key","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"e12656","key":"B123","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12656","article-title":"Physiological basis for muscle stiffness and weakness in a knock-in M1592V mouse model of hyperkalemic periodic paralysis.","volume":"3","author":"Khogali","year":"2015","journal-title":"Physiol. Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3346\/jkms.2007.22.6.946","article-title":"The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.","volume":"22","author":"Kim","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1212\/WNL.0000000000000239","article-title":"A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.","volume":"82","author":"Kokunai","year":"2014","journal-title":"Neurology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","article-title":"Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.","volume":"104","author":"Kornak","year":"2001","journal-title":"Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/cr.2013.89","article-title":"Channel gating pore: a new therapeutic target.","volume":"23","author":"Kornilov","year":"2013","journal-title":"Cell Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/ncpneph0689","article-title":"Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.","volume":"4","author":"Kr\u00e4mer","year":"2008","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neuron.2010.04.030","article-title":"A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome.","volume":"66","author":"Kremeyer","year":"2010","journal-title":"Neuron"},{"key":"B130","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nn.3307","article-title":"Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons.","volume":"16","author":"Krey","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1113\/jphysiol.2010.190652","article-title":"Neurological channelopathies: new insights into disease mechanisms and ion channel function.","volume":"588","author":"Kullmann","year":"2010","journal-title":"J. Physiol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-642-41588-3_5","article-title":"Altered sodium channel gating as molecular basis of pain: contribution of activation, inactivation, and resurgent currents.","volume":"221","author":"Lampert","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1212\/wnl.0000000000001211","article-title":"The phenotypic spectrum of SCN8A encephalopathy.","volume":"84","author":"Larsen","year":"2015","journal-title":"Neurology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1590\/2359-3997000000076","article-title":"Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.","volume":"59","author":"Lau","year":"2015","journal-title":"Arch. Endocrinol. Metab."},{"key":"B135","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/ana.23701","article-title":"Mutations in KCND3 cause spinocerebellar ataxia type 22.","volume":"72","author":"Lee","year":"2012","journal-title":"Ann. Neurol."},{"issue":"10049","key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10049","article-title":"Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant.","volume":"6","author":"Leipold","year":"2015","journal-title":"Nat. Commun."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/ng.2767","article-title":"A de novo gain-of-function mutation in SCN11A causes loss of pain perception.","volume":"45","author":"Leipold","year":"2013","journal-title":"Nat. Genet."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/emboj.2011.137","article-title":"ClC-7 is a slowly voltage-gated 2Cl(-)\/1H(+)-exchanger and requires Ostm1 for transport activity.","volume":"30","author":"Leisle","year":"2011","journal-title":"EMBO J."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/cr.2013.82","article-title":"The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands.","volume":"23","author":"Li","year":"2013","journal-title":"Cell Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.bjp.0706954","article-title":"Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.","volume":"150","author":"Liantonio","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/HJH.0b013e32834d9eb9","article-title":"In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension?","volume":"30","author":"Liantonio","year":"2012","journal-title":"J. Hypertens."},{"key":"B142","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/HJH.0000000000000876","article-title":"Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.","volume":"34","author":"Liantonio","year":"2016","journal-title":"J. Hypertens."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1073\/pnas.0708977105","article-title":"Molecular switch for CLC-K Cl- channel block\/activation: optimal pharmacophoric requirements towards high-affinity ligands.","volume":"105","author":"Liantonio","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","article-title":"SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain.","volume":"75","author":"Liao","year":"2010","journal-title":"Neurology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/jmedgenet-2015-103508","article-title":"KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects.","volume":"53","author":"Lim","year":"2016","journal-title":"J. Med. Genet."},{"key":"B146","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1212\/WNL.0b013e3181ed9e96","article-title":"Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder.","volume":"75","author":"Lion-Francois","year":"2010","journal-title":"Neurology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/hmg\/6.8.1233","article-title":"Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders.","volume":"6","author":"Lloyd","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"B148","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.clinph.2014.06.008","article-title":"Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.","volume":"126","author":"Lo Monaco","year":"2015","journal-title":"Clin. Neurophysiol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ajhg.2011.02.009","article-title":"Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.","volume":"88","author":"L\u00f3pez-Hern\u00e1ndez","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"B150","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/0004563214531403","article-title":"The renal channelopathies.","volume":"51(Pt 4)","author":"Loudon","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"B151","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jcf.2015.06.002","article-title":"Targeting ion channels in cystic fibrosis.","volume":"14","author":"Mall","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"B152","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/humu.22804","article-title":"Mutation update of the CLCN5 gene responsible for dent disease 1.","volume":"36","author":"Mansour-Hendili","year":"2015","journal-title":"Hum. Mutat."},{"key":"B153","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.pediatrneurol.2014.05.027","article-title":"Clinical experience with long-term acetazolamide treatment in children with nondystrophic myotonias: a three-case report.","volume":"51","author":"Markhorst","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1113\/jphysiol.2009.186627","article-title":"Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?","volume":"588","author":"Matthews","year":"2010","journal-title":"J. Physiol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.expneurol.2014.09.003","article-title":"Repurposing of sodium channel antagonists as potential new anti-myotonic drugs.","volume":"261","author":"Matthews","year":"2014","journal-title":"Exp. Neurol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/00000539-200203000-00043","article-title":"The antinociceptive and histologic effect of sciatic nerve blocks with 5% butamben suspension in rats.","volume":"94","author":"McCarthy","year":"2002","journal-title":"Anesth. Analg."},{"key":"B157","doi-asserted-by":"publisher","first-page":"E2724","DOI":"10.1073\/pnas.1220844110","article-title":"Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.","volume":"110","author":"McCormack","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1113\/jphysiol.2010.191767","article-title":"The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet.","volume":"588","author":"McTaggart","year":"2010","journal-title":"J. Physiol."},{"issue":"e00028","key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.28","article-title":"Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle.","volume":"2","author":"Mele","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"issue":"259","key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00259","article-title":"Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels.","volume":"9","author":"Miceli","year":"2015a","journal-title":"Front. Cell Neurosci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1523\/JNEUROSCI.4423-14.2015","article-title":"Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.","volume":"35","author":"Miceli","year":"2015b","journal-title":"J. Neurosci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.bpj.2012.02.004","article-title":"Gating currents from Kv7 channels carrying neuronal hyperexcitability mutations in the voltage-sensing domain.","volume":"102","author":"Miceli","year":"2012","journal-title":"Biophys. J."},{"key":"B163","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10840-015-9998-z","article-title":"The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction.","volume":"43","author":"Milanesi","year":"2015","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"B164","author":"Miller","year":"2014","journal-title":"SCN1A-Related Seizure Disorders."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1113\/jphysiol.2012.228205","article-title":"Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia type 13.","volume":"590","author":"Minassian","year":"2012","journal-title":"J. Physiol."},{"issue":"53","key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00053","article-title":"Biophysics, pathophysiology, and pharmacology of ion channel gating pores.","volume":"5","author":"Moreau","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2013.07.026","article-title":"Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis.","volume":"57","author":"Moscatelli","year":"2013","journal-title":"Bone"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1540-8167.2008.01246.x","article-title":"Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.","volume":"19","author":"Moss","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1021\/jm401864b","article-title":"N-Aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels.","volume":"57","author":"Muraglia","year":"2014","journal-title":"J. Med. Chem."},{"key":"B170","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2008.12.017","article-title":"Spinocerebellar ataxia type 6 (SCA6): Clinical pilot trial with gabapentin.","volume":"278","author":"Nakamura","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jped.2014.01.012","article-title":"Treatment of Bartter syndrome.","volume":"90","author":"Nascimento","year":"2014","journal-title":"Unsolved issue. J. Pediatr."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2013.10.010","article-title":"Andersen-Tawil syndrome: clinical and molecular aspects.","volume":"170","author":"Nguyen","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/ng0110-3","article-title":"No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy.","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nat. Genet."},{"key":"B174","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/embor.2012.219","article-title":"The puzzle of TRPV4 channelopathies.","volume":"14","author":"Nilius","year":"2013","journal-title":"EMBO Rep."},{"key":"B175","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.24331","article-title":"Sodium channel slow inactivation as a therapeutic target for myotonia congenita.","volume":"77","author":"Novak","year":"2015","journal-title":"Ann. Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1126\/science.1188070","article-title":"Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis.","volume":"328","author":"Novarino","year":"2010","journal-title":"Science"},{"key":"B177","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/jpet.113.203331","article-title":"Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.","volume":"345","author":"Oakley","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1212\/WNL.0b013e3181b9cebc","article-title":"De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.","volume":"73","author":"Ogiwara","year":"2009","journal-title":"Neurology"},{"key":"B179","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00210-010-0576-8","article-title":"Antibodies against ClC7 inhibit extracellular acidification-induced ClC currents and bone resorption activity in mouse osteoclasts.","volume":"383","author":"Ohgi","year":"2011","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-physiol-021014-071846","article-title":"Sodium channel \u03b2 subunits: emerging targets in channelopathies.","volume":"77","author":"O\u2019Malley","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.braindev.2010.05.006","article-title":"Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine.","volume":"33","author":"Omata","year":"2011","journal-title":"Brain Dev."},{"key":"B182","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/blood-2015-01-625541","article-title":"Hematopoietic stem cell transplantation for infantile osteopetrosis.","volume":"126","author":"Orchard","year":"2015","journal-title":"Blood"},{"key":"B183","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-neuro-062012-170328","article-title":"Generating human neurons in vitro and using them to understand neuropsychiatric disease.","volume":"37","author":"Pa\u015fca","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-015-1781-6","article-title":"Biophysics and physiology of the volume-regulated anion channel (VRAC)\/volume-sensitive outwardly rectifying anion channel (VSOR).","author":"Pedersen","year":"2016","journal-title":"Pflugers Arch."},{"key":"B185","doi-asserted-by":"publisher","first-page":"15637","DOI":"10.1073\/pnas.0911294107","article-title":"Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier.","volume":"107","author":"Peretz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B186","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature03720","article-title":"Chloride\/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5.","volume":"436","author":"Picollo","year":"2005","journal-title":"Nature"},{"key":"B187","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.bjp.0705284","article-title":"Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor.","volume":"139","author":"Pierno","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/BF00170889","article-title":"Effects of taurine analogues on chloride channel conductance of rat skeletal muscle fibers: a structure-activity relationship investigation.","volume":"349","author":"Pierno","year":"1994","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00424-010-0802-8","article-title":"CaV2.1 channelopathies.","volume":"460","author":"Pietrobon","year":"2010","journal-title":"Pflugers Arch."},{"key":"B190","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine.","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/scd.2015.0258","article-title":"Modeling andersen\u2019s syndrome in human induced pluripotent stem cells.","volume":"25","author":"Pini","year":"2016","journal-title":"Stem Cells Dev."},{"key":"B192","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/35042597","article-title":"ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent\u2019s disease.","volume":"408","author":"Piwon","year":"2000","journal-title":"Nature"},{"key":"B193","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12017-015-8356-8","article-title":"Clinical, molecular, and functional characterization of CLCN1 mutations in three families with recessive myotonia congenita.","volume":"17","author":"Portaro","year":"2015","journal-title":"Neuromol. Med."},{"key":"B194","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/europace\/eut272","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.","volume":"15","author":"Priori","year":"2013","journal-title":"Europace"},{"key":"B196","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/WCO.0b013e32834479a7","article-title":"New and forthcoming anti-epileptic drugs.","volume":"24","author":"Prunetti","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"B197","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/mol.58.3.498","article-title":"Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.","volume":"58","author":"Pusch","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ceca.2014.09.007","article-title":"ClC-5: Physiological role and biophysical mechanisms.","volume":"58","author":"Pusch","year":"2015","journal-title":"Cell Calcium"},{"key":"B199","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1097\/01.ASN.0000036869.82685.F6","article-title":"Responsiveness of hypercalciuria to thiazide in Dent\u2019s disease.","volume":"13","author":"Raja","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2013.11.014","article-title":"Targeting sodium channels in cardiac arrhythmia.","volume":"15","author":"Remme","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.eplepsyres.2014.11.021","article-title":"Current understanding of the mechanism of action of the antiepileptic drug lacosamide.","volume":"110","author":"Rogawski","year":"2015","journal-title":"Epilepsy Res."},{"key":"B202","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/JME-14-0083","article-title":"The insulin-sensitivity sulphonylurea receptor variant is associated with thyrotoxic paralysis.","volume":"53","author":"Rolim","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.bjp.0706895","article-title":"A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo.","volume":"149","author":"Rolland","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","article-title":"Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.","volume":"14","author":"Romano","year":"2015","journal-title":"Lancet Neurol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.hrthm.2015.07.027","article-title":"Carnitine deficiency induces a short QT syndrome.","volume":"13","author":"Roussel","year":"2016","journal-title":"Heart Rhythm"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCRESAHA.110.218891","article-title":"Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.","volume":"106","author":"Ruan","year":"2010","journal-title":"Circ. Res."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"key":"B208","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/brain\/awv142","article-title":"Dissecting the phenotypes of Dravet syndrome by gene deletion.","volume":"138","author":"Rubinstein","year":"2015","journal-title":"Brain"},{"key":"B209","doi-asserted-by":"publisher","first-page":"11037","DOI":"10.1523\/JNEUROSCI.3515-07.2007","article-title":"Modulatory proteins can rescue a trafficking defective epileptogenic NaV1.1 Na+ channel mutant.","volume":"27","author":"Rusconi","year":"2007","journal-title":"J. Neurosci."},{"issue":"592170","key":"B210","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/592170","article-title":"Dual effect of ziconotide in primary erythromelalgia.","volume":"2015","author":"Russo","year":"2015","journal-title":"Case Rep. Med."},{"key":"B211","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","article-title":"Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.","volume":"140","author":"Ryan","year":"2010","journal-title":"Cell"},{"key":"B212","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/humu.20876","article-title":"Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy.","volume":"30","author":"Saint-Martin","year":"2009","journal-title":"Hum. Mutat."},{"key":"B213","doi-asserted-by":"publisher","first-page":"36040","DOI":"10.1074\/jbc.M110.163170","article-title":"Molecular mechanisms of EAST\/SeSAME syndrome mutations in Kir4.1 (KCNJ10).","volume":"285","author":"Sala-Rabanal","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002416","article-title":"Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.","author":"Sansone","year":"2016","journal-title":"Neurology"},{"key":"B215","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1756285615607726","article-title":"Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.","volume":"8","author":"Schoonjans","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1113\/jphysiol.2006.127027","article-title":"A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.","volume":"581","author":"Sheets","year":"2007","journal-title":"J. Physiol."},{"key":"B217","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00002508-200012000-00005","article-title":"Comparison of epidural butamben to celiac plexus neurolytic block for the treatment of the pain of pancreatic cancer.","volume":"16","author":"Shulman","year":"2000","journal-title":"Clin. J. Pain"},{"key":"B218","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1098-7339(98)90014-1","article-title":"Nerve blocks with 5% butamben suspension for the treatment of chronic pain syndromes.","volume":"23","author":"Shulman","year":"1998","journal-title":"Reg. Anesth. Pain. Med."},{"key":"B219","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.nbd.2011.03.016","article-title":"Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1.","volume":"43","author":"Sicca","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B220","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng1097-171","article-title":"Mutations in the chloride channel gene, CLCNKB, cause Bartter\u2019s syndrome type III.","volume":"17","author":"Simon","year":"1997","journal-title":"Nat. Genet."},{"key":"B221","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ng1096-152","article-title":"Genetic heterogeneity of Bartter\u2019s syndrome revealed by mutations in the K+ channel, ROMK.","volume":"14","author":"Simon","year":"1996","journal-title":"Nat. Genet."},{"key":"B222","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.3390\/ijms16024043","article-title":"Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.","volume":"16","author":"Skalova","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B223","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0896-6273(00)81018-1","article-title":"Deletion of the K(V)1.1 potassium channel causes epilepsy in mice.","volume":"20","author":"Smart","year":"1998","journal-title":"Neuron"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.febslet.2015.05.004","article-title":"Changing channels in pain and epilepsy: exploiting ion channel gene therapy for disorders of neuronal hyperexcitability.","volume":"589","author":"Snowball","year":"2015","journal-title":"FEBS Lett."},{"issue":"e00124","key":"B225","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.124","article-title":"Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.","volume":"3","author":"Soares-da-Silva","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"B226","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function.","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature05598","article-title":"Gating pore current in an inherited ion channelopathy.","volume":"446","author":"Sokolov","year":"2007","journal-title":"Nature"},{"key":"B228","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1085\/jgp.201010414","article-title":"Ion permeation and block of the gating pore in the voltage sensor of NaV1.4 channels with hypokalemic periodic paralysis.","volume":"136","author":"Sokolov","year":"2010","journal-title":"J. Gen. Physiol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physiol.00009.2011","article-title":"Driving with no brakes: molecular pathophysiology of Kv7 potassium channels.","volume":"26","author":"Soldovieri","year":"2011","journal-title":"Physiology (Bethesda)"},{"key":"B230","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2147\/TACG.S55762","article-title":"Genetics of inherited primary arrhythmia disorders.","volume":"8","author":"Spears","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"B231","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/jnnp-2015-311233","article-title":"Genetic neurological channelopathies: molecular genetics and clinical phenotypes.","volume":"87","author":"Spillane","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B232","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.","volume":"308","author":"Statland","year":"2012","journal-title":"JAMA"},{"key":"B234","doi-asserted-by":"publisher","first-page":"17390","DOI":"10.1074\/jbc.M114.631705","article-title":"Human CLC-K channels require palmitoylation of their accessory subunit barttin to be functional.","volume":"290","author":"Steinke","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/brain\/124.6.1091","article-title":"Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.","volume":"124","author":"Sternberg","year":"2001","journal-title":"Brain"},{"key":"B236","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/nyas.12774","article-title":"Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research.","volume":"1343","author":"Strupp","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B237","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1085\/jgp.200709755","article-title":"A Na+ channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore.","volume":"130","author":"Struyk","year":"2007","journal-title":"J. Gen. Physiol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jamaneurol.2015.2338","article-title":"Long-term safety and efficacy of mexiletine for patients with skeletal muscle channelopathies.","volume":"72","author":"Suetterlin","year":"2015","journal-title":"JAMA Neurol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1113\/expphysiol.2013.075887","article-title":"Modifiers of heart and muscle function: where genetics meets physiology.","volume":"99","author":"Swaggart","year":"2014","journal-title":"Exp. Physiol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng.3239","article-title":"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.","volume":"47","author":"Syrbe","year":"2015","journal-title":"Nat. Genet."},{"key":"B241","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1113\/jphysiol.2001.012541","article-title":"Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na+ channel.","volume":"537","author":"Takahashi","year":"2001","journal-title":"J. Physiol."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/sj.bjp.0704366","article-title":"Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na+ channels enhancing the antimyotonic activity in vivo.","volume":"134","author":"Talon","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.nbd.2009.04.007","article-title":"A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation.","volume":"35","author":"Tang","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"B244","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.celrep.2015.12.019","article-title":"Epilepsy-related slack channel mutants lead to channel over-activity by two different mechanisms.","volume":"14","author":"Tang","year":"2016","journal-title":"Cell Rep."},{"key":"B245","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen\u2019s syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features.","volume":"35","author":"Tawil","year":"1994","journal-title":"Ann. Neurol."},{"issue":"54","key":"B246","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00054","article-title":"Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes.","volume":"2","author":"Theile","year":"2011","journal-title":"Front. Pharmacol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2014.01.036","article-title":"Modulation of peripheral Na+ channels and neuronal firing by n-butyl-p-aminobenzoate.","volume":"727","author":"Th\u00e9riault","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1124\/mol.112.078212","article-title":"Architecture and pore block of eukaryotic voltage-gated sodium channels in view of NavAb bacterial sodium channel structure.","volume":"82","author":"Tikhonov","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuron.2009.01.027","article-title":"Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice.","volume":"61","author":"Tottene","year":"2009","journal-title":"Neuron"},{"issue":"8","key":"B250","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00008","article-title":"Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies.","volume":"2","author":"Tricarico","year":"2011","journal-title":"Front Pharmacol."},{"issue":"e69551","key":"B251","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069551","article-title":"Emerging role of calcium-activated potassium channel in the regulation of cell viability following potassium ions challenge in HEK293 cells and pharmacological modulation.","volume":"8","author":"Tricarico","year":"2013","journal-title":"PLoS ONE"},{"key":"B252","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1124\/mol.108.046615","article-title":"Molecular determinants for the activating\/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels.","volume":"74","author":"Tricarico","year":"2008a","journal-title":"Mol. Pharmacol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nmd.2005.10.005","article-title":"Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+ channels.","volume":"16","author":"Tricarico","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"B254","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nmd.2007.07.009","article-title":"Reduced expression of Kir6.2\/SUR2A subunits explains KATP deficiency in K+-depleted rats.","volume":"18","author":"Tricarico","year":"2008b","journal-title":"Neuromuscul. Disord."},{"key":"B255","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0960-8966(03)00095-6","article-title":"Involvement of 3Na+\/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin.","volume":"13","author":"Tricarico","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"B256","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1124\/jpet.111.185835","article-title":"Structural nucleotide analogs are potent activators \/ inhibitors of pancreatic \u03b2 cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.","volume":"340","author":"Tricarico","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B257","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1212\/WNL.37.3.488","article-title":"Acetazolamide-responsive myotonia congenita.","volume":"37","author":"Trudell","year":"1987","journal-title":"Neurology"},{"key":"B258","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.coph.2006.01.002","article-title":"Bartter\u2019s and Gitelman\u2019s syndromes: their relationship to the actions of loop and thiazide diuretics.","volume":"6","author":"Unwin","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"B259","article-title":"Megalencephalic Leukoencephalopathy with Subcortical Cysts","author":"van der Knaap","year":"2011","journal-title":"GeneReviews[Internet]"},{"key":"B260","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nbd.2013.10.015","article-title":"Novel SCN3A variants associated with focal epilepsy in children.","volume":"62","author":"Vanoye","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B261","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets.","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"104","key":"B262","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00104","article-title":"Recurrent and non-recurrent mutations of SCN8A in epileptic encephalopathy.","volume":"6","author":"Wagnon","year":"2015","journal-title":"Front. Neurol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/joim.12322","article-title":"Personalized medicine approaches in epilepsy.","volume":"277","author":"Walker","year":"2015","journal-title":"J. Intern. Med."},{"key":"B264","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nn1648","article-title":"Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.","volume":"9","author":"Walter","year":"2006","journal-title":"Nat. Neurosci."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1101\/gad.260869.115","article-title":"CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy.","volume":"29","author":"Wang","year":"2015","journal-title":"Genes Dev."},{"key":"B266","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng0196-17","article-title":"Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias.","volume":"12","author":"Wang","year":"1996","journal-title":"Nat. Genet."},{"key":"B267","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1093\/hmg\/9.20.2937","article-title":"Mice lacking renal chloride channel, CLC-5 are a model for Dent\u2019s disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.","volume":"9","author":"Wang","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"150056","key":"B268","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.150056","article-title":"Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.","volume":"5","author":"Watson","year":"2015","journal-title":"Open Biol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S1474-4422(14)70150-4","article-title":"Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use.","volume":"13","author":"Waxman","year":"2014","journal-title":"Lancet Neurol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"784","DOI":"10.15252\/embr.201438553","article-title":"Transport activity and presence of ClC-7\/Ostm1 complex account for different cellular functions.","volume":"15","author":"Weinert","year":"2014","journal-title":"EMBO Rep"},{"key":"B271","doi-asserted-by":"publisher","first-page":"F849","DOI":"10.1152\/ajprenal.00181.2009","article-title":"A comprehensive guide to the ROMK potassium channel: form and function in health and disease.","volume":"297","author":"Welling","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"150","key":"B272","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0367-x","article-title":"Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.","volume":"10","author":"Welters","year":"2015","journal-title":"Orphanet. J. Rare Dis."},{"key":"B273","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1124\/mol.108.048355","article-title":"Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.","volume":"74","author":"Wheeler","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1093\/brain\/awt280","article-title":"Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.","volume":"136(Pt 12)","author":"Wu","year":"2013","journal-title":"Brain"},{"key":"B275","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1212\/01.wnl.0000275523.95103.36","article-title":"Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations.","volume":"9","author":"Wuttke","year":"2007","journal-title":"Neurology"},{"key":"B276","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1254\/jphs.10R31FM","article-title":"New molecular mechanisms for cardiovascular disease: cardiac hypertrophy and cell-volume regulation.","volume":"116","author":"Yamamoto","year":"2011","journal-title":"J. Pharmacol. Sci."},{"issue":"1186","key":"B277","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2184","article-title":"Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel.","volume":"3","author":"Yang","year":"2012","journal-title":"Nat. Commun."},{"key":"B278","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.","volume":"41","author":"Yang","year":"2004","journal-title":"J. Med. Genet."},{"key":"B279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12265-012-9444-x","article-title":"Modeling Timothy syndrome with iPS cells.","volume":"6","author":"Yazawa","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"B280","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1212\/WNL.0b013e3182904fdd","article-title":"Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation.","volume":"80","author":"Yuan","year":"2013","journal-title":"Neurology"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv352","article-title":"Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or \u2018classical\u2019 congenital myopathy.","author":"Zaharieva","year":"2015","journal-title":"Brain"},{"key":"B282","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential.","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"B283","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ajhg.2013.09.016","article-title":"Gain-of-function mutations in SCN11A cause familial episodic pain.","volume":"93","author":"Zhang","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"B284","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbrc.2009.04.088","article-title":"CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration.","volume":"384","author":"Zhao","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B285","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ddtec.2015.10.003","article-title":"Ion channel profiling to advance drug discovery and development.","volume":"18","author":"Zou","year":"2015","journal-title":"Drug Discov. Today Technol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:32:51Z","timestamp":1748917971000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00121\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":285,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00121","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}